Company Filing History:
Years Active: 2023
Title: Jiangjiang Tang: Innovator in Alzheimer's Disease Treatment
Introduction
Jiangjiang Tang is a notable inventor based in Xianyang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Alzheimer's disease. His innovative work has garnered attention for its potential impact on healthcare.
Latest Patents
Jiangjiang Tang holds a patent for a compound titled "3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof." This patent focuses on a drug designed for the treatment of Alzheimer's disease. The disclosed derivatives demonstrate a significant effect on the inhibition of nitric oxide production, showcasing an effective ECof range of 2.07-5.41 μmol/L. Compared to the positive control group of quercetin and oxiconazole, the derivatives exhibit a stronger inhibitory effect without significant cytotoxicity, maintaining cell viability above 90%. This innovation holds promise for advancing therapeutic options for Alzheimer's patients.
Career Highlights
Jiangjiang Tang is affiliated with Northwest A&F University, where he continues to engage in research and development. His work emphasizes the preparation of acetophenone oxime ether compounds, contributing to the advancement of medicinal chemistry.
Collaborations
Jiangjiang Tang collaborates with esteemed colleagues, including Zhaoyuan Bian and Lanfang Huang. Their combined expertise enhances the research efforts in developing effective treatments for neurodegenerative diseases.
Conclusion
Jiangjiang Tang's innovative contributions to Alzheimer's disease treatment through his patented compounds highlight his role as a significant figure in pharmaceutical research. His work not only advances scientific knowledge but also offers hope for improved therapeutic strategies in combating Alzheimer's disease.